Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IκB kinase epsilon (IKKε) is a serine/threonine protein kinase that plays a central role in the regulation of immune and inflammatory responses, particularly in antiviral defense mechanisms. It is essential for activating type I interferon (IFN), NF-kappa-B, and STAT signaling pathways. IKKε phosphorylates key transcription factors such as IRF3 and IRF7, leading to the induction of pro-inflammatory/antiviral genes. Additionally, it plays a role in energy balance regulation and protects cells against DNA damage-induced cell death. It is considered a therapeutic target due to its roles in both innate immunity/inflammation and tumorigenesis.
Inhibition of IKKε kinase activity, preventing phosphorylation of downstream targets like IRF3/7 and STAT1, thereby suppressing interferon production and inflammatory responses. Direct modulation of TNFA/interleukin-1 signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IκB kinase epsilon (IKKε).